Literature DB >> 16885332

MicroRNA-cancer connection: the beginning of a new tale.

George Adrian Calin1, Carlo Maria Croce.   

Abstract

Cancer initiation and progression can involve microRNAs (miRNA), which are small noncoding RNAs that can regulate gene expression. Their expression profiles can be used for the classification, diagnosis, and prognosis of human malignancies. Loss or amplification of miRNA genes has been reported in a variety of cancers, and altered patterns of miRNA expression may affect cell cycle and survival programs. Germ-line and somatic mutations in miRNAs or polymorphisms in the mRNAs targeted by miRNAs may also contribute to cancer predisposition and progression. We propose that alterations in miRNA genes play a critical role in the pathophysiology of many, perhaps all, human cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885332     DOI: 10.1158/0008-5472.CAN-06-0800

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  408 in total

1.  Identifying targets of human micrornas with the LightSwitch Luciferase Assay System using 3'UTR-reporter constructs and a microRNA mimic in adherent cells.

Authors:  Shelley Force Aldred; Patrick Collins; Nathan Trinklein
Journal:  J Vis Exp       Date:  2011-09-28       Impact factor: 1.355

2.  Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection.

Authors:  Gerard J Nuovo; Xin Wu; Stefano Volinia; Fengting Yan; Gianpiero di Leva; Nena Chin; Alcina F Nicol; Jinmai Jiang; Gregory Otterson; Thomas D Schmittgen; Carlo Croce
Journal:  Diagn Mol Pathol       Date:  2010-09

3.  mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.

Authors:  Hongfang Liu; Petula D'Andrade; Stephanie Fulmer-Smentek; Philip Lorenzi; Kurt W Kohn; John N Weinstein; Yves Pommier; William C Reinhold
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

4.  miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.

Authors:  Hanno Matthaei; Dennis Wylie; Maura B Lloyd; Marco Dal Molin; Jon Kemppainen; Skye C Mayo; Christopher L Wolfgang; Richard D Schulick; Laura Langfield; Bernard F Andruss; Alex T Adai; Ralph H Hruban; Anna E Szafranska-Schwarzbach; Anirban Maitra
Journal:  Clin Cancer Res       Date:  2012-06-21       Impact factor: 12.531

5.  Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Authors:  Sebastian Schwind; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Kelsi B Holland; Dean Margeson; Susan P Whitman; Christopher Hickey; Heiko Becker; Klaus H Metzeler; Peter Paschka; Claudia D Baldus; Shujun Liu; Ramiro Garzon; Bayard L Powell; Jonathan E Kolitz; Andrew J Carroll; Michael A Caligiuri; Richard A Larson; Guido Marcucci; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2010-11-15       Impact factor: 44.544

6.  Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Authors:  Graham M Strub; Andrew L Kirsh; Mark E Whipple; Winston P Kuo; Rachel B Keller; Raj P Kapur; Mark W Majesky; Jonathan A Perkins
Journal:  JCI Insight       Date:  2016-09-08

7.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Authors:  I Martinez; A S Gardiner; K F Board; F A Monzon; R P Edwards; S A Khan
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

8.  p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Authors:  Christian J Braun; Xin Zhang; Irina Savelyeva; Sonja Wolff; Ute M Moll; Troels Schepeler; Torben F Ørntoft; Claus L Andersen; Matthias Dobbelstein
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

9.  Multiplexed microRNA Expression Profiling by Combined Asymmetric PCR and Label-Free Detection using Silicon Photonic Sensor Arrays.

Authors:  Richard M Graybill; Maria C Cardenosa-Rubio; Hongwei Yang; Mark D Johnson; Ryan C Bailey
Journal:  Anal Methods       Date:  2018-03-23       Impact factor: 2.896

10.  A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

Authors:  Amy L Collins; Sylwia Wojcik; James Liu; Wendy L Frankel; Hansjuerg Alder; Lianbo Yu; Thomas D Schmittgen; Carlo M Croce; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.